Cytomegalovirus Reactivation During Maintenance Therapy in Non-transplant Pediatric Acute Lymphoblastic Leukemia
摘要
Cytomegalovirus (CMV) infection is well recognized following hematopoietic stem cell transplantation but remains underappreciated in children receiving chemotherapy outside the transplant setting. Maintenance therapy in acute lymphoblastic leukemia (ALL), characterized by prolonged lymphopenia, may predispose to CMV, particularly in regions with high baseline seroprevalence.
MethodsWe conducted a retrospective, single-center observational case series with focused analytic review of children (≤18 years) with ALL who developed CMV infection during maintenance chemotherapy. Clinical features, hematologic parameters including absolute lymphocyte count (ALC), viral load, management strategies, chemotherapy interruption, and short-term leukemia outcomes were analyzed.
ResultsFour non-transplant pediatric ALL patients developed CMV infection exclusively during maintenance therapy. All were in leukemia remission at CMV diagnosis. CMV infection was consistently associated with treatment-related cytopenias, with lymphopenia (ALC <1,000/µL). Clinical manifestations ranged from fever to gastrointestinal disease. Higher CMV viral loads were associated with end-organ involvement. All patients responded promptly to antiviral therapy achieving rapid virologic clearance. Chemotherapy interruptions were brief (7–10 days) and did not adversely affect leukemia outcomes.
ConclusionsCMV represents a clinically significant but under-recognized complication of maintenance chemotherapy in non-transplant pediatric ALL. CMV evaluation during maintenance, especially if fever is prolonged, may enable early diagnosis and effective treatment.